Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burdenRahel Schwotzer, B. Gerber, Clemens B. Caspar et al.|Hematological Oncology|2019Cited by 34
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandAlden A. Moccia, Felicitas Hitz, Stefanie Aeppli et al.|Hematological Oncology|2020Cited by 15